220 related articles for article (PubMed ID: 18543426)
1. [Using solutions of hydroxyethyl starch (6% HES 200/0.5 (refortan) and 6% HES 130/0.4 (voluven)) in neuroanesthesiology].
Kondrat'ev AN; Novikov VIu; Savvina IA; Driagina NV
Anesteziol Reanimatol; 2008; (2):27-30. PubMed ID: 18543426
[TBL] [Abstract][Full Text] [Related]
2. [Experience with using of solutions of hydroxyethyl starch (refortan and voluven) in neuroanesthesiology].
Kondrat'ev AN; Savvina IA; Novikov VIu; Driagina NV
Vestn Khir Im I I Grek; 2007; 166(6):56-60. PubMed ID: 18411744
[TBL] [Abstract][Full Text] [Related]
3. [Effectiveness and safety of using 6% hydroxyethyl starch 130/04 and 4% modified liquid gelatin in neurosurgical patients with massive intraoperative blood loss].
Israelian LA; Lubnin AIu
Anesteziol Reanimatol; 2009; (5):42-8. PubMed ID: 20491145
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic effects of 6% and 10% hydroxyethyl starch solutions versus 4% albumin solution in septic patients.
Friedman G; Jankowski S; Shahla M; Gomez J; Vincent JL
J Clin Anesth; 2008 Nov; 20(7):528-33. PubMed ID: 19019650
[TBL] [Abstract][Full Text] [Related]
5. [Comparative evaluation of the hemodynamic effect of 6% hydroxyethyl starch 130/0.42 solution versus 4% modified liquid gelatin solution in cardiosurgical patients].
Eremenko AA; Safarov PN
Anesteziol Reanimatol; 2010; (5):49-52. PubMed ID: 21395143
[TBL] [Abstract][Full Text] [Related]
6. Coagulation and biochemical effects of balanced salt-based high molecular weight vs saline-based low molecular weight hydroxyethyl starch solutions during the anhepatic period of liver transplantation.
Ahn HJ; Yang M; Gwak MS; Koo MS; Bang SR; Kim GS; Lee SK
Anaesthesia; 2008 Mar; 63(3):235-42. PubMed ID: 18289228
[TBL] [Abstract][Full Text] [Related]
7. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial.
Schramko AA; Suojaranta-Ylinen RT; Kuitunen AH; Kukkonen SI; Niemi TT
Anesth Analg; 2009 Jan; 108(1):30-6. PubMed ID: 19095827
[TBL] [Abstract][Full Text] [Related]
8. Effects of two different hydroxyethyl starch solutions (HES200/0.5 vs. HES130/0.4) on the expression of platelet membrane glycoprotein.
Chen G; Yan M; Lu QH; Gong M
Acta Anaesthesiol Scand; 2006 Oct; 50(9):1089-94. PubMed ID: 16987338
[TBL] [Abstract][Full Text] [Related]
9. Volume therapy with a new hydroxyethyl starch solution in cardiac surgical patients before cardiopulmonary bypass.
Boldt J; Lehmann A; Römpert R; Haisch G; Isgro F
J Cardiothorac Vasc Anesth; 2000 Jun; 14(3):264-8. PubMed ID: 10890478
[TBL] [Abstract][Full Text] [Related]
10. [Effect of a new 10% hydroxyethyl starch solution HES/270/0.5 on blood coagulation, blood loss and hemodynamics in comparison with 3.5% PPL].
Penner M; Fingerhut D; Tacke A
Infusionstherapie; 1990 Dec; 17(6):314-8. PubMed ID: 1709146
[TBL] [Abstract][Full Text] [Related]
11. Oncotic, hemodilutional, and hemostatic effects of isotonic saline and hydroxyethyl starch solutions in clinically normal ponies.
Jones PA; Tomasic M; Gentry PA
Am J Vet Res; 1997 May; 58(5):541-8. PubMed ID: 9140565
[TBL] [Abstract][Full Text] [Related]
12. [The maximum safe dosage of the low molecular weight hydroxyethyl starch, HESPANDAR (HES), estimated from HES induced changes in coagulation parameters and clinical bleeding].
Saito Y; Uchida K; Yamamoto H; Ichiishi N; Matsushita F
Masui; 1999 Mar; 48(3):238-43. PubMed ID: 10214006
[TBL] [Abstract][Full Text] [Related]
13. Volume replacement therapy during major orthopedic surgery using Voluven (hydroxyethyl starch 130/0.4) or hetastarch.
Gandhi SD; Weiskopf RB; Jungheinrich C; Koorn R; Miller D; Shangraw RE; Prough DS; Baus D; Bepperling F; Warltier DC
Anesthesiology; 2007 Jun; 106(6):1120-7. PubMed ID: 17525586
[TBL] [Abstract][Full Text] [Related]
14. In vitro effects of gelatin solutions on platelet function: a comparison with hydroxyethyl starch solutions.
Thaler U; Deusch E; Kozek-Langenecker SA
Anaesthesia; 2005 Jun; 60(6):554-9. PubMed ID: 15918826
[TBL] [Abstract][Full Text] [Related]
15. The early effect of Voluven, a novel hydroxyethyl starch (130/0.4), on cerebral oxygen supply and consumption in resuscitation of rabbit with acute hemorrhagic shock.
Chen S; Zhu X; Wang Q; Li W; Cheng D; Lei C; Xiong L
J Trauma; 2009 Mar; 66(3):676-82. PubMed ID: 19276737
[TBL] [Abstract][Full Text] [Related]
16. [HES 130/0,4/9:1 effect on intracranial pressure, cerebral blood flow, oxygenation and cerebral vasospasm].
Anesteziol Reanimatol; 2012; (4):63-8. PubMed ID: 23082650
[TBL] [Abstract][Full Text] [Related]
17. Safety of HES 130/0.4 (Voluven(R)) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial.
Godet G; Lehot JJ; Janvier G; Steib A; De Castro V; Coriat P
Eur J Anaesthesiol; 2008 Dec; 25(12):986-94. PubMed ID: 18492315
[TBL] [Abstract][Full Text] [Related]
18. [Polish hydroxyethyl starch preparation: a clinical study].
Schier J; Kościelak J; Szczepanik A; Gryszkiewicz A; Lopaciuk S; Konopka L; Rudowski W
Acta Haematol Pol; 1979; 10(1):51-8. PubMed ID: 86269
[TBL] [Abstract][Full Text] [Related]
19. High-molecular-weight hydroxyethyl starch accelerates kallikrein-dependent clot initiation.
Nielsen VG
J Trauma; 2007 Jun; 62(6):1491-4. PubMed ID: 17563672
[TBL] [Abstract][Full Text] [Related]
20. [Clinical experience with voluven solution used as a basic component for pump oxygenator filling during operations on the cardiac valves and coronary arteries].
Bakanov AIu; Samsonova NN; Akimov IV; Naĭmushin AV; Kadyshkina EB
Anesteziol Reanimatol; 2006; (3):41-5. PubMed ID: 16889212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
